Autoimmune Disorder Therapies: Global Markets
Bharat Book Bureau Provides the Trending Market Research Report on “Autoimmune Disorder Therapies: Global Markets�under Remedies/Therapies Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. The global Autoimmune Disorder Therapies Market was valued at $REDACTED billion in 2019. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion by 2024. Growth of the global market is attributed to factors such as the growing prevalence of obesity, type 1 diabetes and other chronic diseases which leads to autoimmune diseases, a strong product regulatory scenario, and strong investment in research and development activities by key market players including AstraZeneca, Vertex Pharmaceuticals Incorporated, Bristol-Myers Squibb, F. Hoffmann-La Roche AG (Roche), Pfizer Inc., Amgen Inc., AbbVie Inc., Novartis, Johnson and Johnson,Mylan and Bayer. The increasing prevalence of autoimmune diseases, demand for extensive translational research for autoimmune patient treatments, the rise in technological advancements for the diagnosis of autoimmune diseases, and improved awareness about autoimmune diseases are factors expected to fuel the growth of autoimmune disorder therapies market during forecast period. According to the U.S. Department of Health and Human Services, autoimmune diseases affect more than REDACTED million Americans and millions more around the world with an overall prevalence of about REDACTED% disable conditions, associated with significant pain, limitation of movement, and often, loss of independence.The burden of autoimmune diseases is